Coronary Physiology

Category icon
Land Ahoy! – The Holistic Physiology Approach

Barbara Stähli , Stephan Kische, Tommaso Gori et al

Category icon
Coronary Physiology – Can a New Pressure Guidewire Design Expand Adoption?

Evald Høj Christiansen, Pasi Karjalainen, Tim Günter Schäufele

Category icon
Fractional Flow Reserve Expert Consensus

Stephan Achenbach, Tanja Rudolph, Johannes Rieber, et al

Category icon
Imaging Techniques for the Assessment of Coronary Flow Reserve

Mario Petretta, Pierluigi Costanzo, Alberto Cuocolo,

Category icon
Anomalous Coronary Arteries with a Malignant Course

Christoph Gräni, Philipp A Kaufmann, Stephan Windecker, et al

Category icon
‘Combat’ Approach to Cardiogenic Shock

Alexander G Truesdell, Behnam Tehrani, Ramesh Singh, et al

Category icon
Precision Diagnostics in LM Bifurcation Disease

José M de la Torre Hernández, Tamara García Camarero, Andrew SP Sharp et al

About

Invasive coronary physiology is a key instrument in decision making for the interventional cardiologist.

Fractional flow reserve (FFR) has been well validated in chronic stable coronary artery disease. FFR is the ratio of the pressure distal to a lesion relative to the aorta pressure during maximal hyperaemia. Its practical applications are expanding into other clinical situations, including acute coronary syndrome, severe aortic stenosis and post percutaneous coronary intervention.

Instant wave-free ratio (iFR) is a resting index used to assess severity of an intracoronary stenosis. It measures the ratio of mean coronary pressure distal to a stenosis to the mean aortic pressure during an isolated period of diastole – the “wave-free period”.

It is an attractive alternative to FFR because it does not require hyperaemia, and therefore has a lower incidence of patient discomfort, side-effects, and shorter procedural time.

Related Articles

Articles

Management of Coronary Disease in TAVI Patients

Antonio FB de Azevedo Filho, Tarso AD Accorsi, Henrique B Ribeiro,

Published:

Citation: European Cardiology Review 2021;16:e49.

Antithrombotics in LM and Bifurcation PCI

Charalampos Varlamos, Ioannis Lianos, Despoina-Rafailia Benetou,

Published:

Citation: US Cardiology Review 2021;15:e11.

Comments on TARGET FFR and DEFINE-FLOW Trials Presented at TCT Connect 2020

Andreas Seitz, Stefan Baumann, Udo Sechtem,

Published:

Citation: European Cardiology Review 2021;16:e17.

Editorial: The EXCEL Trial

Pablo Avanzas, Juan Carlos Kaski,

Published:

Citation: European Cardiology Review 2021;16:e09.